Live feed07:00:00·1465dPRReleasevia QuantisnowPrecision BioSciences Provides Update on Allogeneic CAR T Programs and Path Forward with Its Lead PBCAR0191 Candidate for CAR T Relapsed Patient PopulationByQuantisnow·Wall Street's wire, on your screen.DTIL· Precision BioSciences Inc.Health Care
